Skip to main content

UTI (STI) Panel

26

NEW STIs EACH YEAR

The CDC estimates that there were more than 26 million new cases of STIs in the United States in 2018 alone.

Source

50

OF OUTPATIENT INFECTIONS

Urinary tract infections (UTIs) are the most common outpatient infections, with a lifetime incidence of 50−60% in adult women.

Source

67

OF UROPATHOGENS ARE MISSED

Studies have shown that up to 67% of uropathogens may be missed with standard urine culture.

Source

PCR & Culture w/ Sensitivity

Run both, together.

Order Here

The New Gold Standard

Our all-in-one UTI/STI panel provides physicians with the ability to detect a broad spectrum of urinary tract pathogens and the presence of corresponding antibiotic resistance markers. This enables clinicians to prescribe the most effective treatments for their patients. Additionally, the use of molecular diagnostic testing for UTIs and STIs eliminates the possibility of “no-growth” results and can identify pathogens that are difficult to detect in traditional urine cultures.

For our UTI/STI panel, we have partnered with Coriell reporting to provide clinicians with suggested treatment options based on the detection of antibiotic resistance markers.

Specimen guide

Sample
Media
Min Volume
Stability - Refrigerated
Stability - Room Temp
Turnaround
Urine
Vacutainer Tube w/ Boric Acid (gray cap)
4mL
48 hours
48 hours
12 hours from receipt